Detection of breast carcinoma metastases in bone: relative merits of X-rays and skeletal scintigraphy
- PMID: 6136757
- DOI: 10.1016/s0140-6736(83)90692-x
Detection of breast carcinoma metastases in bone: relative merits of X-rays and skeletal scintigraphy
Abstract
Of 1116 patients receiving primary treatment for breast carcinoma at the Royal Marsden Hospital since 1976, 651 had an abnormal bone scintigram either at primary diagnosis (378) or on subsequent follow-up (273) and 167 developed radiographically detectable bone metastases (21 at the time of primary diagnosis). Comparison of bone scintigrams and X-rays showed that scintigraphy was an inaccurate localiser of existing radiographic detectable metastases. If X-rays alone are used to detect bone metastases a limited examination with five plates will detect metastases with 92% accuracy. After primary surgery, routine X-ray screening for bone metastases is not necessary since it is possible to identify patients at risk on the basis of clinical examination, chest X-ray, and serum alkaline phosphatase and gamma-glutamyl transpeptidase levels.
Similar articles
-
[Is routine bone scanning justified during the after-care for breast cancer?].Dtsch Med Wochenschr. 1984 Oct 26;109(43):1639-42. doi: 10.1055/s-2008-1069427. Dtsch Med Wochenschr. 1984. PMID: 6149114 German.
-
Detection of bone metastases in patients with breast cancer.Invasion Metastasis. 1982;2(3):177-84. Invasion Metastasis. 1982. PMID: 6234254
-
The value of non-staging skeletal scintigraphy in breast cancer.Clin Radiol. 1986 Nov;37(6):561-2. doi: 10.1016/s0009-9260(86)80020-4. Clin Radiol. 1986. PMID: 3098492
-
Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions.Q J Nucl Med. 2001 Mar;45(1):27-37. Q J Nucl Med. 2001. PMID: 11456373 Review.
-
Preoperative assessment of the patient with breast cancer.Surg Clin North Am. 1984 Dec;64(6):1039-50. doi: 10.1016/s0039-6109(16)43477-8. Surg Clin North Am. 1984. PMID: 6393394 Review.
Cited by
-
Analysis of clinicopathological factors associated with bone metastasis in breast cancer.J Huazhong Univ Sci Technolog Med Sci. 2013 Feb;33(1):122-125. doi: 10.1007/s11596-013-1083-1. Epub 2013 Feb 8. J Huazhong Univ Sci Technolog Med Sci. 2013. PMID: 23392720
-
An analysis of the cost of clinical surveillance after primary therapy for women with early stage invasive breast cancer.Breast Cancer Res Treat. 1996;37(1):39-48. doi: 10.1007/BF01806630. Breast Cancer Res Treat. 1996. PMID: 8750526
-
Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: a comparative study.Med Oncol. 2008;25(3):257-63. doi: 10.1007/s12032-007-9027-x. Epub 2007 Nov 27. Med Oncol. 2008. PMID: 18040900
-
Whither the PET scan? The role of PET imaging in the staging and treatment of breast cancer.Curr Oncol Rep. 2012 Feb;14(1):20-6. doi: 10.1007/s11912-011-0210-z. Curr Oncol Rep. 2012. PMID: 22094933
-
Bone metabolic markers in bone metastases.J Cancer Res Clin Oncol. 1995;121(9-10):542-8. doi: 10.1007/BF01197767. J Cancer Res Clin Oncol. 1995. PMID: 7559734 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical